|
1. Project Evaluation (eNPV) and Licensing
Support
2. R&D Portfolio and Pipeline Analysis
a) Project SWOT Analyses,
considering
|
· |
Attractiveness and drugability of
target(s), mode of action |
|
· |
Technical issues |
|
· |
IP, freedom to
operate, license issues |
|
· |
USPs |
|
· |
Organizational issues |
|
· |
Collaborations |
|
· |
Competitive landscape |
|
· |
Required resources (economic
feasibility) |
|
· |
Market needs |
|
· |
Market
potential |
|
· |
Development
plans (timelines and hurdles) |
b) Identification of Synergistic and Antagonistic
Effects and Potential
·
Technical aspects
·
Organizational
aspects incl. resources
·
Marketing and
strategic aspects
c) Increasing Portfolio Value
·
Portfolio
composition
- Project ranking and reprioritization
- Portfolio restructuring and/or consolidation
- In- and out-licensing of projects,
collaborations
·
Portfolio and project management
-
Allocation and monitoring of resources
- Risk management
-
Integration of functions (discovery research, clinical development, sales
and marketing)
- Communication
- Knowledge management
- Decision tools and criteria
d) Generation of a Quantitative
R&D Pipeline Model
Determination of required resources and
achievements for
desired output (optimization
phase, steady-state)
3. Optimization of Preclinical Research
4. R&D
Benchmarking
5. Multi-Stakeholder Projects
6. Dedicated Investigations (Competition,
Market Research)
7. Generation of Documents and Brochures
8. Part-Time Interims Management
|
